Canton Strategic Sells Its Gravitas Division to Focus on Financial Market Digitization Business

Source: PANews7 hour ago

YouToCoin July 24 news, according to PRNewswire, Nasdaq-listed Canton Strategic Holdings announced the completion of the sale of its biotechnology R&D division Gravitas Life Sciences to Gravitas Collective Corp. The transaction was unanimously approved by the company's board of directors and was completed on July 17, 2026. This sale marks the company's further transformation into an operating enterprise focused on driving the digitization of traditional financial markets through the Canton Network, promoting asset tokenization and financial market digitization as well as financial infrastructure business.

Bullish

Bearish

Popular Exchanges

$1,062,657,337.19

$1,178,487,565.49

$1,095,930,967.45

$6,820,610,021.57

$753,561,985.3

$882,961,417.04